4.4 Review

Autophagy in the Heart: Too Much of a Good Thing?

期刊

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
卷 60, 期 2, 页码 110-117

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FJC.0b013e31824cc427

关键词

cardiac myocytes; autophagy; heart failure; Bnip3; heart; programmed cell death; hypoxia; mitochondria

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. Heart and Stroke Foundation of Canada (HSFC)
  3. CIHR-MHRC Fellowship
  4. IMPACT Strategic Training Program

向作者/读者索取更多资源

Autophagy constitutes a catabolic process involving lysosomal degradation of damaged and redundant cytosolic components into biomolecules, via an elaborate lysosomal pathway. Autophagy is a highly regulated and evolutionary conserved process crucial for normal tissue homeostasis and cell life. Certain members of the Bcl-2 gene family, including the BH3 only protein Bnip3 regulate autophagy during cardiac stress during ischemic or hypoxic injury as means of discarding damaged mitochondria and organelles to avert cell death. Defects in the regulation of autophagy have been associated with a number of human pathologies including cancer, neurodegenerative diseases, and heart failure. Here, we discuss the molecular regulation of autophagy in the heart and cellular demise from too much a good thing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据